Recipient Study Data definition

Recipient Study Data shall have the meaning set forth in Section 8.2.
Sample 1Sample 2Sample 3

Examples of Recipient Study Data in a sentence

  • The name of this organization shall be the Whitman College Panhellenic Association, which includes every sorority member on Whitman College’s campus.

  • All other uses of Combined Therapy Study Data (by either Party), Recipient Study Data (by BMS) and BMS Study Data (by the Recipient) are limited solely to those permitted by this Agreement, and neither Party may use such Study Data for any other purpose without the consent of the other Party during and after the Term.

  • Subject to the provisions of Sections 8.1, each Party shall have access to all Combined Therapy Study Data, Recipient Study Data and BMS Study Data (including de-identified patient records).

  • As between BMS and Recipient, (a) BMS shall own the particular Study Data that relate exclusively to the BMS Study Drug (“ BMS Study Data ”), and the Recipient shall own the particular Study Data that relate exclusively to the Recipient Study Drug (“ Recipient Study Data ”), and (b) both Parties shall jointly own any and all Study Data that is not Recipient Study Data or the BMS Study Data (“ Combined Therapy Study Data ”).

  • Subject to the restrictions on use and disclosure as set forth in this Agreement, both Parties shall jointly own any Study Data that is not BMS Study Data or Recipient Study Data (such jointly owned Study Data being the “Combined Therapy Study Data”).

  • As between BMS and Recipient, (a) BMS shall own the particular Study Data that relate exclusively to the BMS Study Drug (“BMS Study Data”), and the Recipient shall own the particular Study Data that relate exclusively to the Recipient Study Drug (“Recipient Study Data”), and (b) both Parties shall jointly own any and all Study Data that is not Recipient Study Data or the BMS Study Data (“Combined Therapy Study Data”).

  • Recipient may use, analyze and disclose to Third Parties the Recipient Study Data for any purpose without obligation or accounting to BMS.

  • The Recipient agrees to make available to BMS, upon request by BMS, the Recipient Study Data and study data generated in the Monotherapy Arm(s) of the Recipient Clinical Trial for the same indication(s) in which the Combined Therapy is evaluated in the Combined Therapy Study for research purposes relating to the Combined Therapy (including allowing BMS to analyze and estimate contribution of the Recipient FDC and the BMS Study Drug).

Related to Recipient Study Data

  • Study Data shall have the meaning set forth in Section 8.1.

  • Product Data are illustrations, standard schedules, performance charts, instructions, brochures, diagrams, and other information furnished by the Contractor to illustrate materials or equipment for some portion of the Work.

  • Development Data means all non-clinical, clinical, technical, chemical, safety, and scientific data and information and other results, including relevant laboratory notebook information, screening data, and synthesis schemes, including descriptions in any form, data and other information, in each case, that is generated by or resulting from or in connection with the conduct of Development of Products, to the extent that the same are Controlled by or in Adapt’s or its Affiliates’ or Adapt’s Commercial Sublicensees’ possession, and may be disclosed to Lightlake without violating any obligation under Applicable Law.

  • Study Materials means all the materials and information created for the Study, or required to be submitted to the Sponsor including all data, results, Biological Samples, Case Report Forms (or their equivalent) in whatever form held, conclusions, discoveries, inventions, know-how and the like, whether patentable or not, relating to the Study, which are discovered or developed as a result of the Study, but excluding the Institution’s ordinary patient records.

  • Research Data means documents in a digital form, other than scientific publications, which are collected or produced in the course of scientific research activities and are used as evidence in the research process, or are commonly accepted in the research community as necessary to validate research findings and results;

  • Third Party Material means software, software development tools, methodologies, ideas, methods, processes, concepts and techniques owned by, or licensed to a third party and used by the Service Provider in the performance of the Services;

  • Patient Data means any electronic data, information or material about a Patient entered into the Software.

  • Third Party Materials means materials and information, in any form or medium, including any software, documents, data, content, specifications, products, related services, equipment, or components of or relating to the Solutions that are not proprietary to CentralSquare.

  • Receiving Party means the Party receiving Confidential Information.

  • Clinical Data means the information with respect to the Licensed Product or the Licensed Compound made, collected or otherwise generated under or in connection with pre-clinical, clinical, or the post-Approval studies for the Licensed Compound or Licensed Product, including any data, reports and results with respect to any of the foregoing.

  • Receiving Party Personnel has the meaning set forth in Section 37(d).

  • Subject Data As used in this section, “subject data” means recorded information, whether or not copyrighted, that is delivered or specified to be delivered as required by the Underlying Agreement. Examples of subject data include, but are not limited to computer software, standards, specifications, engineering drawings and associated lists, process sheets, manuals, technical reports, catalog item identifications, and related information, but do not include financial reports, cost analyses, or other similar information used for performance or administration of the Underlying Agreement.

  • Program Materials means the documents and information provided by the Program Administrator specifying the qualifying EEMs, technology requirements, costs and other Program requirements, which include, without limitation, program guidelines and requirements, application forms and approval letters.

  • Third-party filer means an entity that submits a Product filing to the Commission on behalf of an Insurer.

  • Regulatory Materials means regulatory applications, submissions, notifications, communications, correspondence, registrations, Regulatory Approvals or other filings made to, received from or otherwise conducted with a Regulatory Authority in order to Develop, Manufacture, or Commercialize a Licensed Product in a particular country or jurisdiction.

  • Product Information has the meaning specified in Section 10.12(a).

  • Proprietary Materials means tangible chemical, biological or physical materials that are furnished by or on behalf of one Party to the other Party in connection with this Agreement, whether or not specifically designated as proprietary by the transferring Party.

  • Detailed manufacturing or process data means technical data that describe the steps, sequences, and conditions of manufacturing, processing or assembly used by the manufacturer to produce an item or component or to perform a process.

  • Third Party Data has the meaning set forth in Section 9.3(a).

  • Buyer Confidential Information has the meaning set out in the Call-Off Contract

  • Client Data means all data or records of whatever nature in whatever form relating to the Client, its operations, facilities, assets, employees, students or otherwise relating to its business, whether subsisting at the date of this Agreement, or created or processed in connection with the Services or as provided by the Client to the Supplier in connection with the Services. Client Data shall include all Client Personal Data

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing and control data, preclinical data, clinical data and all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product (including any applicable Drug Master Files (“DMFs”), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • Regulatory Information Service means any information service authorised from time to time by the FCA for the purpose of disseminating regulatory announcements;

  • Seller Confidential Information has the meaning set forth in Section 6.4.3.

  • Client Materials means the CLIENT Development Materials and the CLIENT Production Materials.

  • Customer Confidential Information means Confidential Information of the Customer provided to Computershare.